Machine Learning and Artificial Intelligence: The integration ofmachine learning and Artificial Intelligence (AI) inpharmacovigilance has revolutionized DDI monitoring. Thesealgorithms can analyze vast datasets, including electronic healthrecords, adverse event reports, and scientific literature, to identifypotential DDIs that might have been missed using traditionalmethods.Predictive modeling: Machine learning models can predictpotential DDIs based on drug properties, such as chemicalstructure, mechanism of action, and pharmacokinetic properties.These models help pharmaceutical companies and regulatoryagencies identify and prioritize DDIs for further investigationduring drug development and post-marketing surveillance.Natural Language Processing (NLP): NLP techniques enablethe extraction of valuable information from unstructureddata sources like medical records and scientific literature